Cluster Engagement: Stockholm Life Science Ecosystem

As part of its pan-European investment strategy, HELIX alpha actively engages with leading life science clusters to build direct relationships with key ecosystem stakeholders.

In this context, HELIX alpha recently visited the Stockholm life science cluster together with its local Country Representative. The exchange included meetings with senior representatives of established cluster organisations, providing on-the-ground insights into one of Europe’s most advanced and internationally connected ecosystems.

Stockholm, in particular the Hagastaden and Flemingsberg submarkets, represents a highly developed life science environment characterised by:

• Strong academic and clinical anchors

• A dense network of biotech and pharma companies

• Continued public and private investment into research infrastructure

• Increasing international visibility and capital inflows
  

Strategic context

For HELIX alpha, such engagements are not isolated activities but part of a broader, structured approach to market access.

The firm systematically builds relationships across Europe’s key life science clusters – including, among others, markets such as Oxford, Barcelona and Heidelberg – to:

• Access proprietary insights beyond transaction-driven processes

• Identify emerging submarkets at an early stage

• Better understand occupier requirements and demand dynamics

• Strengthen local sourcing capabilities and partner networks
  

This cluster-driven approach directly supports HELIX alpha’s focus on core and core+ Life Science Real Estate investments in established and emerging European ecosystems.

By combining local presence with a pan-European perspective, HELIX alpha aims to translate ecosystem intelligence into disciplined investment decisions.